623 related articles for article (PubMed ID: 17308085)
21. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
[TBL] [Abstract][Full Text] [Related]
22. Functional effects of cancer mitochondria on energy metabolism and tumorigenesis: utility of transmitochondrial cybrids.
Kaipparettu BA; Ma Y; Wong LJ
Ann N Y Acad Sci; 2010 Jul; 1201():137-46. PubMed ID: 20649550
[TBL] [Abstract][Full Text] [Related]
23. Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases.
Zhao Y; Bachelier R; Treilleux I; Pujuguet P; Peyruchaud O; Baron R; Clément-Lacroix P; Clézardin P
Cancer Res; 2007 Jun; 67(12):5821-30. PubMed ID: 17575150
[TBL] [Abstract][Full Text] [Related]
24. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
25. Acid production in glycolysis-impaired tumors provides new insights into tumor metabolism.
Helmlinger G; Sckell A; Dellian M; Forbes NS; Jain RK
Clin Cancer Res; 2002 Apr; 8(4):1284-91. PubMed ID: 11948144
[TBL] [Abstract][Full Text] [Related]
26. Pyruvate utilization, phosphocholine and adenosine triphosphate (ATP) are markers of human breast tumor progression: a 31P- and 13C-nuclear magnetic resonance (NMR) spectroscopy study.
Singer S; Souza K; Thilly WG
Cancer Res; 1995 Nov; 55(22):5140-5. PubMed ID: 7585561
[TBL] [Abstract][Full Text] [Related]
27. Energy metabolism in tumor cells.
Moreno-Sánchez R; Rodríguez-Enríquez S; Marín-Hernández A; Saavedra E
FEBS J; 2007 Mar; 274(6):1393-418. PubMed ID: 17302740
[TBL] [Abstract][Full Text] [Related]
28. Profile of energy metabolism in a murine hybridoma: glucose and glutamine utilization.
Petch D; Butler M
J Cell Physiol; 1994 Oct; 161(1):71-6. PubMed ID: 7929610
[TBL] [Abstract][Full Text] [Related]
29. Glucose avidity of carcinomas.
Ortega AD; Sánchez-Aragó M; Giner-Sánchez D; Sánchez-Cenizo L; Willers I; Cuezva JM
Cancer Lett; 2009 Apr; 276(2):125-35. PubMed ID: 18790562
[TBL] [Abstract][Full Text] [Related]
30. The effect of versican G3 domain on local breast cancer invasiveness and bony metastasis.
Yee AJ; Akens M; Yang BL; Finkelstein J; Zheng PS; Deng Z; Yang B
Breast Cancer Res; 2007; 9(4):R47. PubMed ID: 17662123
[TBL] [Abstract][Full Text] [Related]
31. Nerve growth factor is a potential therapeutic target in breast cancer.
Adriaenssens E; Vanhecke E; Saule P; Mougel A; Page A; Romon R; Nurcombe V; Le Bourhis X; Hondermarck H
Cancer Res; 2008 Jan; 68(2):346-51. PubMed ID: 18199526
[TBL] [Abstract][Full Text] [Related]
32. Reovirus as an experimental therapeutic for brain and leptomeningeal metastases from breast cancer.
Yang WQ; Senger DL; Lun XQ; Muzik H; Shi ZQ; Dyck RH; Norman K; Brasher PM; Rewcastle NB; George D; Stewart D; Lee PW; Forsyth PA
Gene Ther; 2004 Nov; 11(21):1579-89. PubMed ID: 15372068
[TBL] [Abstract][Full Text] [Related]
33. Prostate carcinoma cells selected by long-term exposure to reduced oxygen tension show remarkable biochemical plasticity via modulation of superoxide, HIF-1alpha levels, and energy metabolism.
Bourdeau-Heller J; Oberley TD
J Cell Physiol; 2007 Sep; 212(3):744-52. PubMed ID: 17458899
[TBL] [Abstract][Full Text] [Related]
34. D-Serine exposure resulted in gene expression changes indicative of activation of fibrogenic pathways and down-regulation of energy metabolism and oxidative stress response.
Soto A; DelRaso NJ; Schlager JJ; Chan VT
Toxicology; 2008 Jan; 243(1-2):177-92. PubMed ID: 18061331
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
[TBL] [Abstract][Full Text] [Related]
36. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
37. Unexpected preferential brain metastases with a human breast tumor cell line MDA-MB-231 in BALB/c nude mice.
El-Mabhouh AA; Nation PN; Kaddoura A; Mercer JR
Vet Pathol; 2008 Nov; 45(6):941-4. PubMed ID: 18984801
[TBL] [Abstract][Full Text] [Related]
38. Transforming growth factor-beta1 regulation of ATF-3 and identification of ATF-3 target genes in breast cancer cells.
Kwok S; Rittling SR; Partridge NC; Benson CS; Thiyagaraj M; Srinivasan N; Selvamurugan N
J Cell Biochem; 2009 Oct; 108(2):408-14. PubMed ID: 19582787
[TBL] [Abstract][Full Text] [Related]
39. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
Lincoln DT; Singal PK; Al-Banaw A
Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
[TBL] [Abstract][Full Text] [Related]
40. Osteoactivin promotes breast cancer metastasis to bone.
Rose AA; Pepin F; Russo C; Abou Khalil JE; Hallett M; Siegel PM
Mol Cancer Res; 2007 Oct; 5(10):1001-14. PubMed ID: 17951401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
